Medicine recalls
|
| |
| The United States: Cantrell Drug Company issues voluntary nationwide recall of all sterile drug products due to lack of sterility assurance |
| |
The US Food and Drug Administration (FDA) announces that Cantrell Drug Company is voluntarily recalling all lots of unexpired sterile drug products to the hospital and user level due to lack of sterility assurance. Administration of a drug product intended to be sterile that is not sterile could result in serious infections that may be life-threatening. The company is voluntarily issuing a recall out of an abundance of caution after several issues were identified during a recent inspection of its facility.
The recalled products were distributed to health care facilities nationwide, except to the states of Connecticut, Hawaii, South Carolina and Vermont. The affected products include all lots distributed 16 Feb 2017 to 19 Jul 2017, remaining within expiry, and they would be packaged in a syringe or IV bag.
Please refer to the following website in FDA for details:
http://www.fda.gov/Safety/Recalls/ucm568494.htm
In Hong Kong, there is no registered pharmaceutical product manufactured by the above company.
Ends/Wednesday, Jul 26, 2017
Issued at HKT 14:00
|
| |
|
